These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 25463374

  • 1. Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions.
    Cheung JW, Meli AC, Xie W, Mittal S, Reiken S, Wronska A, Xu L, Steinberg JS, Markowitz SM, Iwai S, Lacampagne A, Lerman BB, Marks AR.
    Int J Cardiol; 2015 Feb 01; 180():228-36. PubMed ID: 25463374
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium.
    Meli AC, Refaat MM, Dura M, Reiken S, Wronska A, Wojciak J, Carroll J, Scheinman MM, Marks AR.
    Circ Res; 2011 Jul 22; 109(3):281-90. PubMed ID: 21659649
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.
    Domingo D, Neco P, Fernández-Pons E, Zissimopoulos S, Molina P, Olagüe J, Suárez-Mier MP, Lai FA, Gómez AM, Zorio E.
    Rev Esp Cardiol (Engl Ed); 2015 May 22; 68(5):398-407. PubMed ID: 25440180
    [Abstract] [Full Text] [Related]

  • 6. The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.
    Xiao Z, Guo W, Yuen SM, Wang R, Zhang L, Van Petegem F, Chen SR.
    PLoS One; 2015 May 22; 10(9):e0139058. PubMed ID: 26405799
    [Abstract] [Full Text] [Related]

  • 7. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT, Valdivia CR, Gurrola GB, Powers PP, Willis BC, Moss RL, Jalife J, Valdivia HH.
    Proc Natl Acad Sci U S A; 2015 Mar 31; 112(13):E1669-77. PubMed ID: 25775566
    [Abstract] [Full Text] [Related]

  • 8. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.
    Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR.
    Circulation; 2004 Jun 29; 109(25):3208-14. PubMed ID: 15197150
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D, Jones PP, Davis DR, Gow R, Green MS, Birnie DH, Chen SR, Gollob MH.
    Channels (Austin); 2010 Jun 29; 4(4):302-10. PubMed ID: 20676041
    [Abstract] [Full Text] [Related]

  • 10. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.
    Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ.
    Heart Rhythm; 2007 Jun 29; 4(6):733-9. PubMed ID: 17556193
    [Abstract] [Full Text] [Related]

  • 11. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B, Guo A, Gao Z, Wei S, Xie YP, Chen SR, Anderson ME, Song LS.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):841-9. PubMed ID: 22722659
    [Abstract] [Full Text] [Related]

  • 12. A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia.
    Fujii Y, Itoh H, Ohno S, Murayama T, Kurebayashi N, Aoki H, Blancard M, Nakagawa Y, Yamamoto S, Matsui Y, Ichikawa M, Sonoda K, Ozawa T, Ohkubo K, Watanabe I, Guicheney P, Horie M.
    Heart Rhythm; 2017 Jan 01; 14(1):98-107. PubMed ID: 27756708
    [Abstract] [Full Text] [Related]

  • 13. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK, Riediger F, Pagonas N, Nordbeck P, Ritter O, Sasko B.
    J Med Case Rep; 2018 Oct 09; 12(1):298. PubMed ID: 30296944
    [Abstract] [Full Text] [Related]

  • 14. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Neco P, Torrente AG, Mesirca P, Zorio E, Liu N, Priori SG, Napolitano C, Richard S, Benitah JP, Mangoni ME, Gómez AM.
    Circulation; 2012 Jul 24; 126(4):392-401. PubMed ID: 22711277
    [Abstract] [Full Text] [Related]

  • 15. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC, Li N, Wang Q, Word TA, Sibrian-Vazquez M, Strongin RM, Wehrens XHT, Abramson JJ.
    Heart Rhythm; 2018 Apr 24; 15(4):578-586. PubMed ID: 29248564
    [Abstract] [Full Text] [Related]

  • 16. R4496C RyR2 mutation impairs atrial and ventricular contractility.
    Ferrantini C, Coppini R, Scellini B, Ferrara C, Pioner JM, Mazzoni L, Priori S, Cerbai E, Tesi C, Poggesi C.
    J Gen Physiol; 2016 Jan 24; 147(1):39-52. PubMed ID: 26666913
    [Abstract] [Full Text] [Related]

  • 17. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M.
    Circ Res; 2010 Apr 30; 106(8):1413-24. PubMed ID: 20224043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.